Gabapentin Capsule
Product Images NDC 71205-638

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71205-638). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapentin 01)

Chemical structure of Gabapentin showing its cyclohexane ring with attached amine (CH2NH2) and carboxylic acid (CH2CO2H) functional groups.*

FDA Label Image

Figure 1 (Gabapentin 02)

A line graph comparing mean pain scores over 8 weeks between placebo and Gabapentin 3600 mg/day. The x-axis shows weeks from baseline to week 8. The y-axis shows mean pain scores from 0 to 10. Two phases are indicated: a 4-week dose titration period followed by a 4-week fixed dose period. Gabapentin shows a decreasing pain score trend, while placebo remains relatively stable.*

FDA Label Image

Figure 2 (Gabapentin 03)

A line chart showing mean pain scores over a 7-week period comparing placebo and two doses of Gabapentin (1800 mg/day and 2400 mg/day). The x-axis represents weeks, with labeled periods for a 3-week dose titration and a 4-week fixed dose. The y-axis represents mean pain scores from 0 to 10. Gabapentin groups show a greater decrease in pain scores compared to placebo over time.*

FDA Label Image

Figure 3 (Gabapentin 04)

A bar graph titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It shows data from two studies comparing placebo (PBO) to Gabapentin (GBP) at various dosages. Study 1 compares PBO (12%) to GBP 3600 mg (29%). Study 2 compares PBO (14%) to GBP 1800 mg (32%) and GBP 2400 mg (34%). Statistical significance levels are noted with asterisks for p-values < 0.01 and < 0.001.*

FDA Label Image

Figure 4 (Gabapentin 05)

A line and bar chart comparing percentage differences across three studies (A, B, C) at daily doses of 600, 900, 1200, and 1800 mg. The y-axis represents difference percentage, and the x-axis shows increasing gabapentin daily dosage in milligrams.*

FDA Label Image

71205-638-30 (Gabapentin 06)

The image shows a ProficientRx label for Gabapentin 100 mg capsules, containing 30 capsules per package. It includes details such as the dosage form (capsules), medication guide instructions, and capsule description with opaque white gelatin shell and black ink imprint. Labeler is Proficient Rx LP, with packaging location in Thousand Oaks, CA. The NDC number is 71205-638-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.